PharmQAReg_TUDublin
439 posts
PharmQAReg_TUDublin
@pharmqareg
E. Harris, Programme Chair MSc Pharm QA & Reg TU Dublin. Interested in all things Pharm QA & Regulations, particularly innovative medicines/medical device/ATMPs
Dublin City, Ireland Katılım Mayıs 2022
549 Takip Edilen121 Takipçiler
A great big welcome/failte to all our new MSc students. Lots of ways to say hello in the class.
English
Delighted to meet all our new MSc PharmaQA&Regulation students at induction yesterday. Really looking forward to the new academic year.
English
PharmQAReg_TUDublin retweetledi
🔍 Our website provides clear and comprehensive information about cancer clinical trials that are open in 🇮🇪.
Every trial listed represents amazing work by investigators and site staff, and, crucially, hope for patients.
🌐bit.ly/4edteFV
#CancerResearch
English
My most recent publication on therapeutic delivery developments, with news on licensing agreements for both Pulmatrix and Enable for their platform technologies iSPERSE™ and enFuse™
Industry Update, May 2024 tandfonline.com/doi/full/10.10…
English
PharmQAReg_TUDublin retweetledi
From concept creation, to finalising the storyboard - I very much enjoyed being involved in the production of this terrific animation. Thanks to all involved!
English
PharmQAReg_TUDublin retweetledi
Delighted to see two posters based on @SiobhanGaynor #MetastaticBreastcancer survey on display at #ESMOBREAST24 presented by @RCPI_Trainees @drRachelJKeogh and @CathWeadick 👏
This patient-led research will lead to real changes in the patient experience 💪
English
PharmQAReg_TUDublin retweetledi
Huge 🙏to @SiobhanGaynor for her tireless work on MBC survey. Tks to 🇮🇪 MBC community for taking part! 4⃣ abstracts submitted & full report in development with @Seamusoreilly18 @franduane1 @yvonneo_meara @drRachelJKeogh @CathWeadick & CTI team!
@AngelaClaytonL1 @EibhlinMulroe
English
A great day’s training @NIBRT_ for our MSc students. Thanks to the team at NIBRT for such an enjoyable and worthwhile day.
English
PharmQAReg_TUDublin retweetledi
It has been another week of milestones in the #cellandgenetherapy sector.
✅The first T cell therapy for solid tumor cancer is FDA-approved
🧬The EU approved its first-ever CRISPR gene editing therapy
🔬FDA accepts application for efficacy supplement in DMD gene therapy
🧵1/4
English
Are you completing a level 8 degree in science, engineering or related areas & considering a postgrad qualification to allow you have a career as a quality professional in Pharma/Biopharma industry? Applications now open for our MSc Pharm QA & Regulation tudublin.ie/study/postgrad…
English
PharmQAReg_TUDublin retweetledi
Roche has made a fast U-turn on Repare Therapeutics’ synthetic lethal drug candidate. Days after dosing a ph. 2 patient and triggering a $40M payment, Roche told the oncology biotech that it will hand back the asset. fiercebiotech.com/biotech/roche-…
English
Excellent review and perfect summary for students on our Innovative Medicines module, thanks!
Alliance for Regenerative Medicine (ARM)@alliancerm
2023 was a milestone year for #geneediting. How far has this science come, and where is it heading? Cassandra Willyard of MIT Technology Review explains how the technology is now living up to its potential and which innovations are around the corner. technologyreview.com/2023/12/22/108…
English
PharmQAReg_TUDublin retweetledi
The FDA has issued a new draft guidance advising certain product sponsors to establish data monitoring committees to ensure that safety signals are detected early. bit.ly/42EMrLp
English
PharmQAReg_TUDublin retweetledi
CSL Behring’s largest-ever trial has ended in failure, as the Australian pharma revealed that its cholesterol efflux enhancer was unable to reduce the risk of heart attacks. fiercebiotech.com/biotech/csls-m…
English
My most recent publication a round-up of industry-relevant therapeutic delivery stories: validation of ENHANZE technology with approval of argenx's VYVGART, a co-development agreement for Halozyme & Acumen, a positive CHMP opinion for Roche's Tecentriq SC
future-science.com/doi/10.4155/td…
English
A round-up of some of the top stories in therapeutic delivery with validation of the ENHANZE technology with the approval of argenx's VYVGART, a co-development agreement between Halozyme & Acumen a positive CHMP opinion for Roche's Tecentriq SC future-science.com/doi/10.4155/td…
English
Class 1 recall by FDA due to possible sterility issues
FDA Medical Devices@FDADeviceInfo
Today, the @US_FDA identified a Class I Recall, the most serious type of recall: ROi CPS, LLC is recalling their Regard Operative Lap P&S Surgical Kit due to the possibility they may not be sterile. fond out more about this #MedicalDevice recall. fda.gov/medical-device…
English
Super opportunity in the area of novel optical sensors!
Dervil Cody@DervilCody
📣Interested in a fully-funded PhD at @IEO_Centre and @WeAreTUDublin on the development of novel optical sensors for evaluation of focused ultrasound systems? Then apply to the @MedDevDoc doctoral programme! Please get in touch if you are eligible! #PhD #photonics #medicalphysics
English